Eyenuk Inc.’s AI-based diabetic retinopathy screening software EyeArt™ tested with portable smartphone-based imaging device in new study indicating potential for highly sensitive yet cost-effective mass retinal screening

Nature Eye Article

A new study published in the international ‘Eye’ journal (Springer Nature) demonstrated very high sensitivity for detecting any diabetic retinopathy (95.8%) and sight-threatening diabetic retinopathy (99.1%) using EyeArt™ automated screening software with Remidio Fundus on Phone system. LOS ANGELES, CA, March 12, 2018 — Eyenuk, Inc., a leading developer of advanced clinically supported artificial intelligence […]

Continue Reading »

Diabetic Retinopathy Screening

NEI_DR

It starts out small enough.  Your vision seems slightly blurred.  At first you just think it’s a sign of increasing age; you notice that reading text is a little harder.  But after a few months it seems to get worse.  Eventually you go to your doctor, and he refers you to an ophthalmologist.  After hearing […]

Continue Reading »

Large UK National Health Services (NHS) Study Finds Eyeart Device To Be The Most Sensitive Automated Retinal Image Analysis Technology For Diabetic Retinopathy Screening

WOODLAND HILLS, Calif. – May 2, 2016 – Eyenuk, Inc., developer of advanced retinal image analysis solutions to identify eye disease, today announced results from the first large-scale, independent, comparative study of automated diabetic retinopathy (DR) screening technologies, showing that its EyeArt™ software device rated highest among those tested in sensitivity across all types of […]

Continue Reading »